Sangamo Therapeutics, Inc (SGMOQ): Shares Outstanding
350.69M
As of 2025-12-31
+28.1%
3-year compound annual growth
+19.8%
5-year compound annual growth
+17.4%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 350.69M | +64.8% | 2026-03-30, Balance as of period end |
| 2024-12-31 | 212.84M | +19.5% | 2026-03-30, Balance as of period end |
| 2023-12-31 | 178.13M | +6.8% | 2025-03-17, Balance as of period end |
| 2022-12-31 | 166.79M | +14.3% | 2024-03-13, Balance as of period end |
| 2021-12-31 | 145.92M | +2.7% | 2023-02-23, Balance as of period end |
| 2020-12-31 | 142.06M | +22.5% | 2022-02-24, Balance as of period end |
| 2019-12-31 | 115.97M | +13.5% | 2021-02-24, Balance as of period end |
| 2018-12-31 | 102.19M | +19.4% | 2020-02-28, Balance as of period end |
| 2017-12-31 | 85.60M | +20.8% | 2019-03-01, Balance as of period end |
| 2016-12-31 | 70.87M | +0.7% | 2018-03-01, Balance as of period end |
| 2015-12-31 | 70.35M | +1.9% | 2017-02-28, Balance as of period end |
| 2014-12-31 | 69.06M | +11.0% | 2016-02-18, Balance as of period end |
| 2013-12-31 | 62.24M | +17.3% | 2015-02-25, Balance as of period end |
| 2012-12-31 | 53.06M | +1.0% | 2014-02-24, Balance as of period end |
| 2011-12-31 | 52.55M | +15.8% | 2013-02-26, Balance as of period end |
| 2010-12-31 | 45.38M | n/a | 2012-02-23, Balance as of period end |